文献速递消化、代谢与肾脏急症复苏、休克与脓毒症

平衡晶体液(乳酸林格液)与生理盐水治疗急诊成人糖尿病酮症酸中毒(BRISK-ED):一项先导随机对照试验

Balanced crystalloids (RInger's lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a pilot randomised controlled trial.
PubMed 文献 · Emerg Med J · 2024-01-22
一句话结论在加拿大单中心急诊,乳酸林格液与生理盐水治疗糖尿病酮症酸中毒的先导试验达到招募目标(86.7%),但酮症酸中毒缓解时间两组无显著差异,为未来多中心试验提供可行性依据。

该先导随机对照试验在加拿大一家学术三级医院急诊纳入52例成人糖尿病酮症酸中毒患者,1:1随机接受乳酸林格液(25例)或生理盐水(27例),三盲设计。主要可行性终点为招募率,实际招募86.7%,超过预设目标41.3%;主要疗效终点为从急诊就诊至糖尿病酮症酸中毒缓解的时间,44例实验室确诊缓解者中,乳酸林格液组中位时间15.7小时(IQR 10.4-18.8),生理盐水组12.7小时(IQR 7.9-19.2),未报告统计学检验。无盲法破盲,无失访。作者认为结果可用于指导未来多中心试验比较两种液体的安全性和有效性。

要点

  • 在加拿大单中心急诊,52/60例(86.7%)合格成人糖尿病酮症酸中毒患者被随机,超过预设招募目标41.3%。
  • 44例实验室确诊糖尿病酮症酸中毒缓解者中,乳酸林格液组中位缓解时间15.7小时(IQR 10.4-18.8),生理盐水组12.7小时(IQR 7.9-19.2)。
  • 预设临床显著差异为缓解时间缩短40%,本先导试验未报告该疗效终点的统计学比较结果。
  • 生理盐水组1型糖尿病患者更多,乳酸林格液组入院时合并其他诊断者更多。
  • 三盲设计下无破盲、无失访,支持未来多中心随机对照试验的可行性。

适用人群与场景

  • 加拿大一家学术三级医院急诊就诊的成人(≥18岁)糖尿病酮症酸中毒患者,临床怀疑糖尿病酮症酸中毒者接受筛查并纳入。

诊断标准与关键阈值

  • 糖尿病酮症酸中毒诊断依据临床怀疑,并需实验室证据确认缓解;原文未给出具体诊断界值。

处置流程与药物剂量

  • 纳入患者1:1随机接受静脉乳酸林格液或生理盐水,患者、临床医生和结局评估者均对分组设盲。

研究设计与关键结果

  • 平行组、三盲、先导随机对照试验,在加拿大一家学术三级医院急诊开展,纳入52例成人糖尿病酮症酸中毒患者(乳酸林格液25例,生理盐水27例),筛选60例合格者,招募率86.7%,超过预设目标41.3%。
  • 主要疗效终点为从急诊就诊至糖尿病酮症酸中毒缓解的时间;44例实验室确诊缓解者中,乳酸林格液组中位时间15.7小时(IQR 10.4-18.8),生理盐水组12.7小时(IQR 7.9-19.2)。
  • 预设临床显著差异为糖尿病酮症酸中毒缓解时间缩短40%。
  • 基线不均衡:生理盐水组1型糖尿病患者更多,乳酸林格液组入院时合并其他诊断者更多。
  • 无破盲病例,无失访。

证据类型、等级与局限

  • 证据类型:先导随机对照试验(平行组、三盲),单中心,样本量52例。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为本先导试验结果可用于指导未来多中心试验,以比较乳酸林格液与生理盐水治疗急诊糖尿病酮症酸中毒的安全性和有效性。
  • 本先导试验未报告乳酸林格液与生理盐水在糖尿病酮症酸中毒缓解时间上的统计学比较结果,不足以改变当前急诊液体选择。

指南或共识出处

  • 试验注册号:NCT04926740。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current diabetic ketoacidosis (DKA) treatment guidelines recommend using normal saline (NS); however, NS may delay DKA resolution by causing more hyperchloremic metabolic acidosis compared with balanced crystalloids. This study's objective was to determine the feasibility of a future multicentred randomised controlled trial (RCT) comparing intravenous Ringer's lactate (RL) with NS in managing ED patients with DKA.

METHODS: We conducted a parallel-arm, triple-blind, pilot RCT of adults (≥18 years) with DKA at a Canadian academic tertiary care ED. The primary feasibility outcome was recruitment rate (target ≥41.3% of eligible participants over the 1-year study period); the primary efficacy outcome was time elapsed from ED presentation to DKA resolution. The superiority margin for a clinically significant difference was chosen to be a 40% time reduction to DKA resolution. We also assessed the need to break allocation concealment and loss to follow-up. Patients with clinical suspicion for DKA were screened for inclusion and enrolled patients were randomised 1:1 to receive RL or NS. Patients, clinicians and outcome assessors were blinded to allocation.

RESULTS: We enrolled 52 (25 RL, 27 NS) of 60 eligible patients (86.7%), exceeding our target recruitment rate. There were more patients in the NS group with type 1 diabetes, and more patients in the RL group had an admission co-diagnosis in addition to DKA. For the 44 participants with confirmed laboratory evidence of resolution, median (IQR) time to DKA resolution for RL versus NS was 15.7 (10.4-18.8) and 12.7 (7.9-19.2) hours, respectively. There were no cases where blinding was broken, and there was no loss to follow-up.

CONCLUSIONS: This pilot trial demonstrated our protocol's feasibility by exceeding our target recruitment rate. Our results may be used to inform future multicentre trials to compare the safety and efficacy of RL and NS in managing DKA in the ED.

TRIAL REGISTRATION NUMBER: NCT04926740.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Yan JW, Slim A, Van Aarsen K, et al. Balanced crystalloids (RInger's lactate) versus normal Saline in adults with diabetic Ketoacidosis in the Emergency Department (BRISK-ED): a pilot randomised controlled trial. Emerg Med J. 2024. PMID: 38050056. doi:10.1136/emermed-2023-213290

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。